FDA approves new larger production setup for Genmab drug
After the US health authorities approved a new production setup at Horizon Therapeutics, which holds the rights to Genmab's drug Tepezza, the company expects that current supply-related issues will soon be resolved.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Read this article for free
Register with your E-mail. No credit card required.